Biofrontera Warrants Stock Fundamentals
| BFRIW Stock | USD 0.10 0.02 16.67% |
Biofrontera Warrants fundamentals help investors to digest information that contributes to Biofrontera Warrants' financial success or failures. It also enables traders to predict the movement of Biofrontera Stock. The fundamental analysis module provides a way to measure Biofrontera Warrants' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biofrontera Warrants stock.
At this time, Biofrontera Warrants' Tax Provision is fairly stable compared to the past year. Interest Income is likely to climb to about 202.9 K in 2025, whereas Selling General Administrative is likely to drop slightly above 34.7 M in 2025. Biofrontera | Select Account or Indicator |
Biofrontera Warrants Company Operating Margin Analysis
Biofrontera Warrants' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Biofrontera Warrants Operating Margin | (0.55) % |
Most of Biofrontera Warrants' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biofrontera Warrants is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBiofrontera Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Biofrontera Warrants has an Operating Margin of -0.5504%. This is 98.43% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The operating margin for all United States stocks is 90.01% lower than that of the firm.
Biofrontera Warrants Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biofrontera Warrants's current stock value. Our valuation model uses many indicators to compare Biofrontera Warrants value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biofrontera Warrants competition to find correlations between indicators driving Biofrontera Warrants's intrinsic value. More Info.Biofrontera Warrants is rated fifth in return on equity category among its peers. It is rated third in return on asset category among its peers . At this time, Biofrontera Warrants' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biofrontera Warrants by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Biofrontera Fundamentals
| Return On Equity | -3.91 | ||||
| Return On Asset | -0.46 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.55) % | ||||
| Number Of Shares Shorted | 259 | ||||
| Revenue | 34.07 M | ||||
| Gross Profit | 16.66 M | ||||
| EBITDA | (18.45 M) | ||||
| Net Income | (20.13 M) | ||||
| Total Debt | 5.4 M | ||||
| Book Value Per Share | 0.85 X | ||||
| Cash Flow From Operations | (24.89 M) | ||||
| Earnings Per Share | (1.30) X | ||||
| Number Of Employees | 83 | ||||
| Beta | 0.3 | ||||
| Total Asset | 27.93 M | ||||
| Retained Earnings | (99.65 M) | ||||
| Working Capital | 4.99 M | ||||
| Net Asset | 27.93 M |
About Biofrontera Warrants Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biofrontera Warrants's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biofrontera Warrants using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biofrontera Warrants based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 24.3 K | 23.1 K | |
| Total Revenue | 39.2 M | 29 M | |
| Cost Of Revenue | 20.1 M | 14.7 M | |
| Stock Based Compensation To Revenue | 0.03 | 0.03 | |
| Sales General And Administrative To Revenue | 1.00 | 0.95 | |
| Revenue Per Share | 25.34 | 33.65 | |
| Ebit Per Revenue | (0.77) | (0.80) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Biofrontera Stock Analysis
When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.